Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending July 07, 2006. The report serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding Ordinary Shares of the Company.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a regulatory notification of share transactions and does not contain financial performance data.
Material Changes
The filing details specific share transfers from the GlaxoSmithKline Employee Trust ("GSK Trust") to participants in the SmithKline Beecham Employee Share Option Plan 1991:
- July 5, 2006: Transfer of 29,770 Ordinary Shares.
- July 6, 2006: Transfer of 96,823 Ordinary Shares.
These transactions were advised to the Company on July 7, 2006.
Management Commentary and Risks
The GSK Trust is identified as a discretionary trust where all current and former employees of GlaxoSmithKline plc and its subsidiaries are potential beneficiaries. The filing notes that three directors (Dr J-P Garnier, Dr M M Slaoui, and Mr J S Heslop) hold an interest in the shares held by the GSK Trust in the same capacity as other employees. No specific risks, contingencies, or unusual items beyond the standard disclosure of these transactions are mentioned.
Investor Verification Points
- Verify the total number of shares transferred (126,593) against the company's total outstanding share count to assess dilution impact.
- Confirm the specific terms of the SmithKline Beecham Employee Share Option Plan 1991 regarding vesting and exercise conditions.
- Review the full list of directors and their specific holdings to understand the scope of "Connected Persons" interests.